| Product Name | MF | CAS | Details |
|---|
| 4-Bromo-2-fluoro-n-methoxy-n-methylbenzamide | C9H9BrFNO2 | 801303-33-3 | Details |
| tert-butyl (R)-3-methyl-1,4-diazepane-1-carboxylate | C11H22N2O2 | 223644-10-8 | Details |
| CFI-402257 | C28H30N6O3 | 1610759-22-2 | Details |
| 2-Methoxy-4-(Trifluoromethyl)Phenol | C8H7F3O2 | 1027888-79-4 | Details |
| NX-1607 | C30H34F3N5O | 2573775-59-2 | Details |
| AK-1690 | C51H56F2N5O11PS | 2984505-88-4 | Details |
| 2-Fluorobiphenyl-4-carboxylic acid | C13H9FO2 | 137045-30-8 | Details |
| N-(4-Bromo-2-fluorobenzoyl)morpholine | C11H11BrFNO2 | 924642-61-5 | Details |
| 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline | C10H12N4O | 1609394-10-6 | Details |
| AZD0156 | C26H31N5O3 | 1821428-35-6 | Details |
| 4,6-dichloro-N-(methyl-d3)pyridazine-3-carboxamide | C6H2Cl2D3N3O | 1609393-89-6 | Details |
| (R)-N-(5-((5-(4-acryloyl-3-methyl-1,4-diazepane-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)cyclopropanecarboxamide | C25H30N4O4S2 | 2226636-04-8 | Details |
| Lunresertib; RP-6306 | C18H20N4O2 | 2719793-90-3 | Details |
| AGI-43192 | C23H16ClF3N6O | 2377491-54-6 | Details |
| 4-fluoro-N-(1-methylpiperidin-4-yl)benzamide | C13H17FN2O | 210643-93-9 | Details |
| NP3-253 | 2557349-50-3 | Details |
| PT-2385 | C17H12F3NO4S | 1672665-49-4 | Details |
| DNL-758;SAR-443122;Eclitasertib，5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazepin-3-yl]-2H-1,2,4-triazole-3-carboxamide | C19H18N6O3 | 2125450-76-0 | Details |
| ZM-H1505R; Canocapavir | C27H21BrFN5O3 | 2137847-19-7 | Details |
| IDEAYA-1 | C16H14ClN5O3S | 2882953-29-7 | Details |
| MRT-6160 | C22H17ClN2O3 | 3050683-38-7 | Details |
| Givinostat | C24H27N3O4 | 497833-27-9 | Details |
| Selinexor; KPT-330 | C17H11F6N7O | 1393477-72-9 | Details |
| Eganelisib; IPI-549 | C30H24N8O2 | 1693758-51-8 | Details |
| AZD1390 | C27H32FN5O2 | 2089288-03-7 | Details |
| AZD4144 | C18H16F3N3O3 | 2890191-41-8 | Details |
| 2-Methoxy-5-(trifluoromethyl)phenol | C8H7F3O2 | 349-67-7 | Details |
| GSK2982772，5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl]-2H-1,2,4-triazole-3-carboxamide | C20H19N5O3 | 1622848-92-3 | Details |
| 2-Nitro-4-(trifluoromethyl)benzyl alcohol | C8H6F3NO3 | 133605-27-3 | Details |
| Emlenoflast; MCC7840 | C19H24N4O3S | 1995067-59-8 | Details |
| BMS-986299 | C18H19N7O | 2242952-69-6 | Details |
| Osunprotafib; ABBV-CLS-484; AC484 | C17H24FN3O4S | 2489404-97-7 | Details |
| BMS-502 | 2407854-18-4 | Details |
| AG-270; S-095033 | C30H27N5O2 | 2201056-66-6 | Details |
| XD2-149 | C38H39N5O8 | 2710221-08-0 | Details |
| 2-Fluoro-4-iodobenzonitrile | C7H3FIN | 137553-42-5 | Details |
| NDI-091143 | C20H14ClF2NO5S | 2375840-87-0 | Details |
| Ensitrelvir | C30H33N5O5S | 1471484-62-4 | Details |
| 5-methylsulfanylpyrimidin-2-amine | C5H7N3S | 7367-94-4 | Details |
| RI962，1-methyl-5-{2-[(2-methylpropanoyl)amino][1,2,4]triazolo[1,5-a]pyridin-7-yl}-N-(1-phenylethyl)indole-3-carboxamide | C28H28N6O2 | 2763831-53-2 | Details |
| IDEAYA-4 | C20H20ClN5O5S | 2782815-65-8 | Details |
| Deucravacitinib | C9H8N4O3 | 1609394-05-9 | Details |
| LP-935509 | C20H24N6O3 | 1454555-29-3 | Details |
| 4,6-Dichloro-N-methylnicotinamide | C7H6Cl2N2O | 1609530-95-1 | Details |
| Pentanamide | C16H19F2N3O3 | 1644248-18-9 | Details |
| JBI-589 | C29H28FN5O | 2308504-22-3 | Details |
| 4-Bromo-2-fluoro-N,N-dimethylbenzamide | C9H9BrFNO | 749927-80-8 | Details |
| 4-Bromo-N-cyclopropyl-2-fluorobenzamide | C10H9BrFNO | 877383-84-1 | Details |
| Dapansutrile; OLT-1177 | C4H7NO2S | 54863-37-5 | Details |
| 4-Hydroxy-3-(trifluoromethoxy)benzonitrile | C8H4F3NO2 | 1093397-72-8 | Details |
| AZ-28 | C16H14ClN3O | 2439271-82-4 | Details |
| N-(2-ethynyl-5-(trifluoromethyl)phenyl)acetamide | C11H8F3NO | 1436417-15-0 | Details |
| RO-7623066; RG-6614; KSQ-4279 | C27H25F3N8O | 2446480-97-1 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||